Results 211 to 220 of about 66,809 (256)
Some of the next articles are maybe not open access.
2019
The rapidly increasing healthcare spending, particularly on prescription drug, is a pressing issue in the United States and deserves comprehensive and in-depth analysis. In this dissertation, I investigate three topics that are highly relevant yet less researched under the current policy discussion of reforming Medicare by using empirical data from ...
openaire +1 more source
The rapidly increasing healthcare spending, particularly on prescription drug, is a pressing issue in the United States and deserves comprehensive and in-depth analysis. In this dissertation, I investigate three topics that are highly relevant yet less researched under the current policy discussion of reforming Medicare by using empirical data from ...
openaire +1 more source
Medication Therapy Management in Medicare Part D
The Senior Care Pharmacist, 2022Medication Therapy Management (MTM) is not just a good idea–it is the law. Included in the provisions of the Medicare Modernization Act of 2003 and codified into the Social Security Act is the legal mandate for a program to identify at-risk individuals with chronic disease conditions and an expected consumption of Part D drugs that reached a ...
openaire +2 more sources
The Impact of Medicare Part D on Self-Employment
Research on Aging, 2016We explore the relationship between access to affordable health insurance and self-employment using exogenous variation from the introduction of Medicare Part D that reduced the out-of-pocket cost of prescription drugs and improved health outcomes in a difference-in-differences model using the American Community Survey. We find that our treatment group
Jeremy G, Moulton +2 more
openaire +2 more sources
Assessing the Effect of the Medicare Part D Redesign
JAMAThis Viewpoint focuses on the Manufacturer Discount Program, identifying 4 key themes of interest to policymakers that may be affected by its Part D redesign.
Rachel E, Sachs, Richard G, Frank
openaire +2 more sources
Pharmacists, Medicare Part D, and the antikickback statute
American Journal of Health-System Pharmacy, 2006It is well documented that the new Medicare prescription drug benefit is causing a great deal of confusion among those eligible for Medicare. What is receiving far less attention is the confusion among the pharmacists who are expected to help patients understand this drug benefit program.
openaire +2 more sources
Case Managers and the Useof Medicare, Part D
Professional Case Management, 2011The purpose of this study was to examine the experiences and opinions of community-based mental health case managers with the Medicare prescription drug benefit. A qualitative approach, consisting of analysis of data from 3 case manager focus groups, was used to achieve an understanding of the role that case managers played in beneficiaries' access to ...
openaire +2 more sources
Your Money or Your Life — The High Cost of Cancer Drugs Under Medicare Part D
New England Journal of Medicine, 2022Stacie B. Dusetzina
exaly
Medicare Part D Coverage of Antiobesity Medications — Challenges and Uncertainty Ahead
New England Journal of Medicine, 2023Ashley A Leech, Stacie B. Dusetzina
exaly